Prognostic Value of PRISMA-7 Score for Frail Elderly Patients with Advanced Pancreatic Adenocarcinoma

Abstract

Finding the prognostic factors for this dismal disease is still challenging, especially for elderly patients. Patient age [1,2], performance status [1], blood neutrophil-lymphocyte ratio [3], Plasma Chromogranin A [4], frailty index [5] are documented as prognostic factors for outcome of the patients with advanced pancreatic cancer. Data about elderly patients in these trials is limited. We present our practice regarding the importance of frailty index called PRISMA7 (Program of Research to Integrate the Services for the Maintenance of Autonomy-7) score for prognostic stratification of elderly patients with advanced pancreatic cancer. It was highly significant prognostic factor for those patients.